Emerging Therapeutic Strategies for COVID-19 patients

Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shudong, Guo, Xialing, Geary, Kyla, Zhang, Dianzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Applied Systems srl 2020
Materias:
Focused Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093072/
https://www.ncbi.nlm.nih.gov/pubmed/32309622
http://dx.doi.org/10.15190/d.2020.2
_version_ 1783510226115231744
author Zhu, Shudong
Guo, Xialing
Geary, Kyla
Zhang, Dianzheng
author_facet Zhu, Shudong
Guo, Xialing
Geary, Kyla
Zhang, Dianzheng
author_sort Zhu, Shudong
collection PubMed
description Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.
format Online
Article
Text
id pubmed-7093072
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Applied Systems srl
record_format MEDLINE/PubMed
spelling pubmed-70930722020-04-08 Emerging Therapeutic Strategies for COVID-19 patients Zhu, Shudong Guo, Xialing Geary, Kyla Zhang, Dianzheng Discoveries (Craiova) Focused Review Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention. Applied Systems srl 2020-03-12 /pmc/articles/PMC7093072/ /pubmed/32309622 http://dx.doi.org/10.15190/d.2020.2 Text en Copyright: © 2020, Zhu et al. and Applied Systems http://creativecommons.org/licenses/by/4.0/ This article is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Focused Review
Zhu, Shudong
Guo, Xialing
Geary, Kyla
Zhang, Dianzheng
Emerging Therapeutic Strategies for COVID-19 patients
title Emerging Therapeutic Strategies for COVID-19 patients
title_full Emerging Therapeutic Strategies for COVID-19 patients
title_fullStr Emerging Therapeutic Strategies for COVID-19 patients
title_full_unstemmed Emerging Therapeutic Strategies for COVID-19 patients
title_short Emerging Therapeutic Strategies for COVID-19 patients
title_sort emerging therapeutic strategies for covid-19 patients
topic Focused Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093072/
https://www.ncbi.nlm.nih.gov/pubmed/32309622
http://dx.doi.org/10.15190/d.2020.2
work_keys_str_mv AT zhushudong emergingtherapeuticstrategiesforcovid19patients
AT guoxialing emergingtherapeuticstrategiesforcovid19patients
AT gearykyla emergingtherapeuticstrategiesforcovid19patients
AT zhangdianzheng emergingtherapeuticstrategiesforcovid19patients

Ejemplares similares